SM
ONCS

Sabby Management’s OncoSec Medical Incorporated ONCS Stock Holding History

Sabby Management’s Portfolio ONCS Stock Details ONCS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-696
Closed -$249K – 220
2017
Q4 		$249K Sell
696
-3,896
-85% -$1.36M 0.02% 119
2017
Q3 		$968K Buy
4,592
+192
+4% +$42.8K 0.06% 75
2017
Q2 		$1.15M Sell
4,400
-36
-0.8% -$8.83K 0.08% 97
2017
Q1 		$1.25M Sell
4,436
-900
-17% -$262K 0.07% 120
2016
Q4 		$1.44M Buy
5,336
+1,545
+41% +$530K 0.08% 127
2016
Q3 		$1.43M Buy
3,791
+1,027
+37% +$393K 0.05% 155
2016
Q2 		$997K Sell
2,764
-2,288
-45% -$964K 0.05% 159
2016
Q1 		$2.83M Sell
5,052
-513
-9% -$219K 0.14% 73
2015
Q4 		$2.9M Buy
5,565
+4,019
+260% +$3.02M 0.16% 94
2015
Q3 		$1.75M Sell
1,546
-1,944
-56% -$2.55M 0.07% 172
2015
Q2 		$4.86M Buy
+3,490
New +$5.23M 0.18% 96

Other funds holding ONCS

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
NC
Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Sabby Management's ONCS Position: Q1 2018 in Review

Sabby Management sold out of OncoSec Medical Incorporated (ONCS) in Q1 2018, closing a stake of 696 shares — an estimated $249K sold.

Sabby Management first reported a position in ONCS in Q2 2015 and held it in 11 quarters. The position peaked at $4.86M in Q2 2015. 38 funds tracked by Wall St. Rank hold ONCS as of Q1 2018.

  • Sabby Management reported no remaining OncoSec Medical Incorporated position as of Q1 2018 after selling out during the quarter.
  • Sabby Management sold 696 OncoSec Medical Incorporated shares in Q1 2018, an estimated $249K.
  • Sabby Management first reported a position in OncoSec Medical Incorporated in Q2 2015 and held it in 11 quarters.
  • Sabby Management's OncoSec Medical Incorporated position peaked at $4.86M in Q2 2015.
  • 38 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q1 2018.

Based on Sabby Management's 13F filing for Q1 2018, filed 15 May 2018.